Body composition improvement

Body composition improvement refers to the favorable alteration of the ratio between fat mass and lean mass, typically involving the reduction of adiposity and the preservation or increase of skeletal muscle. This is a critical therapeutic goal in the treatment of obesity, sarcopenia, and metabolic disorders, as traditional weight loss interventions often result in the detrimental loss of muscle tissue alongside fat. Modern pharmacological strategies aim to achieve this through diverse molecular targets, such as the Glucagon-like peptide 1 receptor (GLP-1R) for appetite control and the Myostatin/Activin pathway for muscle protection. Monitoring this endpoint requires precise imaging techniques like DXA or MRI to ensure that weight reduction is primarily driven by fat loss while maintaining physical function and metabolic health.

Other names

Body composition changeFat-to-lean mass ratio optimizationMetabolic recompositionLean mass preservationSarcopenic obesity treatment

Body composition improvement is a physiological outcome resulting from various mechanisms including GLP-1/GIP receptor agonism (promoting fat loss via appetite suppression), Myostatin/Activin receptor inhibition (preventing muscle atrophy), and Growth Hormone axis stimulation (enhancing protein synthesis).